Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Award-Winning Writers and Illustrators of the Future Experience Live Performance of L. Ron Hubbard’s Pulp Fiction Story
    Award-Winning Writers and Illustrators of the Future Experience Live Performance of L. Ron Hubbard’s Pulp Fiction Story World News
  • Deputy Secretary Sherman’s Call with Swiss State Secretary Leu
    Deputy Secretary Sherman’s Call with Swiss State Secretary Leu World News
  • War Day 110: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych  & #Feygin
    War Day 110: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin World News
  • International African Energy, Oil & Gas Summit (IAEOGS) 2025 Set for August in Namibia Amid Record Investment Growth
    International African Energy, Oil & Gas Summit (IAEOGS) 2025 Set for August in Namibia Amid Record Investment Growth Business
  • Musipple by Ziqiang He, Hao Zhang and Yunan Lin Wins Bronze in A’ Audio Equipment Awards
    Musipple by Ziqiang He, Hao Zhang and Yunan Lin Wins Bronze in A’ Audio Equipment Awards World News
  • Northwind Pharmaceuticals Adds Health Intelligence Innovator Rod Reasen to Advisory Board
    Northwind Pharmaceuticals Adds Health Intelligence Innovator Rod Reasen to Advisory Board Business
  • War Day 234: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 234: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • WOMEN’S MONTH AND GENDER EQUAILTY ALSO MEANS ADVOCATING FOR FINANCIAL FREEDOM FOR WOMEN
    WOMEN’S MONTH AND GENDER EQUAILTY ALSO MEANS ADVOCATING FOR FINANCIAL FREEDOM FOR WOMEN Business
Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Posted on November 15, 2024 By NewsEditor

Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Solaris Endovascular Inc

Solaris SX is very flexible

Solaris SX Flexibility

NEW ORLEANS, LA, UNITED STATES, November 13, 2024 /EINPresswire.com/ — Solaris Endovascular, Inc. Launching to Address Vascular Health Challenges Globally

Solaris Endovascular, Inc. proudly announces its formation to develop solutions for Dialysis Access and Peripheral Artery Disease (PAD). Solaris Endovascular develops evidence-based technologies, intended to treat and extend the patency of dialysis access fistulae, grafts, and peripheral arteries to allow patients to lead healthier lives with fewer interventions.

End-Stage Kidney Disease (ESKD) is a major health concern affecting approximately 10 million people worldwide with approximately 3 million people receiving kidney replacement therapy and relying on hemodialysis to survive. Over 50% of these patients experience vascular access failures within the first year and are subjected to hospital admissions and repeated costly endovascular or surgical interventions to restore their lifeline to dialysis—this drastically impacts quality of life, treatment effectiveness and survival.

In April 2024, the American Heart Association reported that the global prevalence of peripheral artery disease (PAD) may be as high as 230 million people. PAD can progress from painful walking to critical limb ischemia, and many patients require revascularization procedures to restore blood flow, improve symptoms, or prevent amputations.

Stent-grafts are emerging as the preferred minimally invasive treatment for these conditions and Solaris Endovascular is currently selling the latest generation of stent-grafts. The flagship Solaris(TM) SX Vascular Stent Graft employs the most advanced electrospinning PTFE impermeable membrane that prevents tissue ingrowth, maximizes patency, and reduces restenosis. This thin, multi-directional PTFE membrane encapsulates a nitinol stent that provides flexibility, high radial strength, and crush resistance for optimal blood flow. These features are already proven in global markets with more than 13,000 units sold to date. Interventional and endovascular physicians worldwide have chosen Solaris SX for its trackability and precise pinpoint deployment, ensuring accurate placement.

“Bringing this innovative technology to the United States is a major step forward in improving the lives of patients,” said Dr. Marco Costa, Chairman and Chief Medical & Scientific Officer at Solaris Endovascular Inc. “Solaris Endovascular’s advanced covered stent platforms will not only reduce the burden of repeated interventions but will also dramatically enhance the quality of life and life expectancy for those who suffer from these debilitating conditions.”

Looking ahead, Solaris Endovascular is already enrolling patients in clinical trials for the first of its kind Solaris(TM) DE Drug-Eluting Vascular Stent Graft – that will address the remaining unmet need in covered stents: edge stenosis. Solaris DE incorporates Sirolimus, a powerful and safe anti-proliferative agent that revolutionized the treatment of coronary artery disease with the virtual elimination of restenosis, from 30% to 3%.

“We expect Solaris DE to deliver similar transformative results to patients with ESKD and PAD,” said Dr. Costa.

CEO Randy Hubbell emphasized the company’s unique position in the market: “Solaris Endovascular represents a rare opportunity to start a new company that is revenue producing from the beginning, has a decade-plus manufacturing expertise in stents, stent grafts and endovascular drug delivery, and a proven product supported by clinical studies in multiple markets before entering the U.S. Our platform addresses a significant unmet need in both dialysis access and PAD, offering life-changing solutions for patients while setting a new standard in endovascular care.”

As Solaris Endovascular prepares for the U.S. registration process, it is committed to driving meaningful improvements in patient outcomes, reducing hospital readmissions, and lowering overall healthcare costs.

About Solaris Endovascular, Inc.

Solaris Endovascular, Inc. is a growth stage US-based medical device company developing advanced endovascular solutions for patients suffering from dialysis access challenges and Peripheral Artery Disease. With a proven stent platform and innovative drug-eluting technology, led by seasoned executives with extensive experience in cardiovascular MedTech, Solaris Endovascular is uniquely positioned and committed to improving long-term patient outcomes and transforming vascular health.

For more information, please visit: [www.solarisendovascular.com]

Randy Hubbell
Solaris Endovascular, Inc.
[email protected]
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

News Provided By

November 13, 2024, 13:30 GMT

Distribution channels:
Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry, Beauty & Hair Care, Business & Economy, Chemical Industry, Companies, Conferences & Trade Fairs, Culture, Society & Lifestyle, Education, Emergency Services …


EIN Presswire’s priority is author transparency. We do our best to weed out false and misleading content. The content above is
the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.

Article originally published on www.einpresswire.com as Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Business

Post navigation

Previous Post: Maria Cecilia Conder selected as Top Board Member of the Year in Fine Arts by IAOTP
Next Post: Tech and Social Impact Leaders Converge at Goodera’s AI for Impact Summit

Related Posts

  • Sean McQuaid Wins Best Attorney for Tampa Bay’s Best of the Bay
    Sean McQuaid Wins Best Attorney for Tampa Bay’s Best of the Bay Business
  • Canadian Resort and Travel Association (CRTA) Names New Board Member
    Canadian Resort and Travel Association (CRTA) Names New Board Member Business
  • Atlanta-Based Digital Marketing Company Interactive Search Marketing Has Announced Their Rebranding to Grater Digital
    Atlanta-Based Digital Marketing Company Interactive Search Marketing Has Announced Their Rebranding to Grater Digital Business
  • BrightMove Wins Gold Stevie Award in 2023 Stevie(R) Awards for Sales & Customer Service
    BrightMove Wins Gold Stevie Award in 2023 Stevie(R) Awards for Sales & Customer Service Business
  • Shooting And Gun Accessories Market Size, Share And Growth Analysis For 2024-2033
    Shooting And Gun Accessories Market Size, Share And Growth Analysis For 2024-2033 Business
  • Mini Mall Storage Offers Climate Control and Vehicle Storage in Brandon, Manitoba
    Mini Mall Storage Offers Climate Control and Vehicle Storage in Brandon, Manitoba Business
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
« Jun    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Thousands Unite Globally for The Trueness Project’s ‘Grand Butterfly Gathering’ to Promote Peace and TransformationJuly 22, 2025
  • Household Cleaners Market is Expected to Develop at a CAGR of 4.6% from 2022 to 2031July 22, 2025
  • Global Nomad Pass Members Now Get Airport Lounge Access Worldwide Through New Lounge Pass PartnershipJuly 22, 2025
  • War in Ukraine, Analytics. Day 1236: Ministers Changed. Trumps Ultimatum. Arestovych, Shelest.July 22, 2025
  • iVoice Launches Global Direct Democracy Platform, Empowering Citizens to Take Control of Their FutureJuly 21, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Chiang Mai Lantern Festival 2025 Confirmed for November 5–6
    Chiang Mai Lantern Festival 2025 Confirmed for November 5–6 Aviation
  • Global Distribution Transformers Market to Reach USD 56.4 Billion by 2035, Driven by Grid Modernization and Renewables
    Global Distribution Transformers Market to Reach USD 56.4 Billion by 2035, Driven by Grid Modernization and Renewables Business
  • International Venture Capitalist and Founder/CEO of TrüNorth Global and Waystone Capital Comes Home to Invest and Reimagine Hometown
    International Venture Capitalist and Founder/CEO of TrüNorth Global and Waystone Capital Comes Home to Invest and Reimagine Hometown Business
  • PMCF Advises Two Corrugated Packaging Industry Transactions in Third Quarter 2022
    PMCF Advises Two Corrugated Packaging Industry Transactions in Third Quarter 2022 Business
  • Pakistani social entrepreneur Sophia Hussain takes over Silicon Valley in STEM, says her idol is Benazir Bhutto.
    Pakistani social entrepreneur Sophia Hussain takes over Silicon Valley in STEM, says her idol is Benazir Bhutto. World News
  • Thousands Unite Globally for The Trueness Project’s ‘Grand Butterfly Gathering’ to Promote Peace and Transformation
    Thousands Unite Globally for The Trueness Project’s ‘Grand Butterfly Gathering’ to Promote Peace and Transformation World News
  • nogaholding Partners With GHGSat for High-Resolution Satellite Data
    nogaholding Partners With GHGSat for High-Resolution Satellite Data Business
  • Experts Explain the Importance of First-Party Data as Online Privacy Concerns Increase
    Experts Explain the Importance of First-Party Data as Online Privacy Concerns Increase Business
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .